Abstract. The characteristics of ozone variations and the impacts of synoptic and local meteorological factors in northern China were quantitatively analyzed during the warm season from 2013 to 2017 based on multi-city in situ ozone and meteorological data as well as meteorological reanalysis. The domain-averaged maximum daily 8 h running average O3 (MDA8 O3) concentration was 122±11 µg m−3, with an increase rate of 7.88 µg m−3 yr−1, and the three most polluted months were closely related to the variations in the synoptic circulation patterns, which occurred in June (149 µg m−3), May (138 µg m−3) and July (132 µg m−3). A total of 26 weather types (merged into five weather categories) were objectively identified using the Lamb–Jenkinson method. The highly polluted weather categories included the S–W–N directions (geostrophic wind direction diverts from south to north), low-pressure-related weather types (LP) and cyclone type, which the study area controlled by a low-pressure center (C), and the corresponding domain-averaged MDA8 O3 concentrations were 122, 126 and 128 µg m−3, respectively. Based on the frequency and intensity changes of the synoptic circulation patterns, 39.2 % of the interannual increase in the domain-averaged O3 from 2013 to 2017 was attributed to synoptic changes, and the intensity of the synoptic circulation patterns was the dominant factor. Using synoptic classification and local meteorological factors, the segmented synoptic-regression approach was established to evaluate and forecast daily ozone variability on an urban scale. The results showed that this method is practical in most cities, and the dominant factors are the maximum temperature, southerly winds, relative humidity on the previous day and on the same day, and total cloud cover. Overall, 41 %–63 % of the day-to-day variability in the MDA8 O3 concentrations was due to local meteorological variations in most cities over northern China, except for two cities: QHD (Qinhuangdao) at 34 % and ZZ (Zhengzhou) at 20 %. Our quantitative exploration of the influence of both synoptic and local meteorological factors on interannual and day-to-day ozone variability will provide a scientific basis for evaluating emission reduction measures that have been implemented by the national and local governments to mitigate air pollution in northern China.

No abstract

Background The protective effect of melatonin against bone metabolism imbalance in osteoporosis (OP) induced by drugs such as retinoic acid (RA) is unclear. The aim of this study was to explore the role of melatonin in bone destruction based on a mouse model. Methods RA-induced OP model mice were established. To assess the effect of melatonin on these mice, micro-CT was used to characterize the trabecular structure of normal mice and those treated with RA (model), RA + low-dose melatonin (Mlt-L), RA + high-dose melatonin (Mlt-H), and RA + alendronate sodium (positive control). The shape of the trabecular bone, the length and diameter of the femoral head and the height and diameter of vertebra(L1) of each group were also measured and the number of osteoclasts was determined by Tartrate-resistant acid phosphatase (TRACP) staining. Meanwhile, the expression of alkaline phosphatase (ALP) was evaluated by immunohistochemistry assays. The differences between groups in terms of liver and kidney oxidation–related indexes and serum and urinary indicators related to bone metabolism were also analyzed. Furthermore, qRT-PCR and western blotting were used to evaluate the effect of melatonin on osteogenic and osteoclastic differentiation in MC3T3-E1 and RAW264.7 cells, respectively. Results RA induction led to a decrease in the amount and density of trabecular bone, a decrease in the length and diameter of the femur and height, diameter of the vertebra (L1), a decrease in bone mass and density and the expression of ALP, and an increase in the number of osteoclasts. Melatonin treatment alleviated these effects induced by RA, increasing the amount of trabecular bone in OP mice, improving the microstructure of the femur and vertebra(L1) and increasing bone mass bone density and the expression of ALP, as well as decreasing the number of osteoclasts. Additionally, blood and urinary bone metabolism-related indicators showed that melatonin promoted bone formation and inhibited bone resorption. Determination of oxidant and antioxidant biomarkers in the livers and kidneys of the mice revealed that melatonin promoted the antioxidant level and suppressed the level of oxidant molecules in these organs. In vitro, RA promoted osteoclasts and inhibit osteogenesis by increasing oxidative stress levels in the RAW264.7 and MC3T3-E1 cells, but melatonin reversed this effect. Melatonin may, therefore, play a role in the ERK/SMAD and NF-κB pathways. Conclusions Melatonin can alleviate bone loss in RA-induced OP model mice, repair the trabecular microstructure, and promote bone formation. These effects may be related to reducing oxidation levels in vivo and vitro through the ERK/SMAD and NF-κB pathways. Electronic supplementary material The online version of this article (10.1186/s10020-019-0107-0) contains supplementary material, which is available to authorized users.

No abstract

Heterotopic ossification (HO) occurs as a common complication after injury or in genetic disorders. The mechanisms underlying HO remain incompletely understood, and there are no approved prophylactic or secondary treatments available. Here, we identify a self-amplifying, self-propagating loop of Yes-associated protein (YAP)–Sonic hedgehog (SHH) as a core molecular mechanism underlying diverse forms of HO. In mouse models of progressive osseous heteroplasia (POH), a disease caused by null mutations in GNAS, we found that Gnas−/− mesenchymal cells secreted SHH, which induced osteoblast differentiation of the surrounding wild-type cells. We further showed that loss of Gnas led to activation of YAP transcription activity, which directly drove Shh expression. Secreted SHH further induced YAP activation, Shh expression, and osteoblast differentiation in surrounding wild-type cells. This self-propagating positive feedback loop was both necessary and sufficient for HO expansion and could act independently of Gnas in fibrodysplasia ossificans progressiva (FOP), another genetic HO, and nonhereditary HO mouse models. Genetic or pharmacological inhibition of YAP or SHH abolished HO in POH and FOP and acquired HO mouse models without affecting normal bone homeostasis, providing a previously unrecognized therapeutic rationale to prevent, reduce, and shrink HO.